Rheumatoid Arthritis Management with Celecoxib and Ibuprofen

Safety Profile and Efficacy

The American College of Rheumatology recommends that for patients with a history of symptomatic or complicated upper GI ulcer but no bleeding in the past year, either a COX-2 selective inhibitor (like celecoxib) or a non-selective NSAID with a proton-pump inhibitor is strongly recommended, with a focus on minimizing gastrointestinal toxicity 2
For patients aged ≥75 years, topical NSAIDs are strongly recommended over oral NSAIDs (including both celecoxib and ibuprofen) due to reduced gastrointestinal risk 2
The gastrointestinal safety advantage of celecoxib is particularly important for long-term management of chronic conditions like rheumatoid arthritis, with studies showing a lower incidence of upper gastrointestinal ulcer complications compared to non-selective NSAIDs like ibuprofen 1

Patients taking low-dose aspirin for cardioprotection should avoid ibuprofen due to a pharmacodynamic interaction that may reduce aspirin's cardioprotective effects, highlighting the need for careful medication management 2
Neither celecoxib nor ibuprofen should be used in patients with chronic kidney disease stage IV or V (eGFR <30 ml/min), emphasizing the importance of renal function assessment prior to NSAID initiation 2